(Total Views: 262)
Posted On: 03/13/2018 3:40:22 PM
Post# of 11803
Re: veritas011 #4287
A few of my take-aways from today's PR:
GenChoice/Ladybug has completed 1st stage clinical testing.
March 15 - GenChoice progresses to IRB controlled clinical trial.
May 2018 - GenChoice completion of clinical trials.
GenChoice - 45 Days from conclusion of clinical trials a 510K application for market clearance will be filed with the U.S. FDA.
GenChoice - Introduction to International markets in June 2018 as a prelude to the eventual U.S. introduction.
GenChoice - expected to be the largest of the 3 revenue producers (GenSure & GenUltimate are the others).
GenChoice/Ladybug has completed 1st stage clinical testing.
March 15 - GenChoice progresses to IRB controlled clinical trial.
May 2018 - GenChoice completion of clinical trials.
GenChoice - 45 Days from conclusion of clinical trials a 510K application for market clearance will be filed with the U.S. FDA.
GenChoice - Introduction to International markets in June 2018 as a prelude to the eventual U.S. introduction.
GenChoice - expected to be the largest of the 3 revenue producers (GenSure & GenUltimate are the others).
(3)
(0)
